Brian R. Rood, M.D.

  • Director, Clinical Neuro-Oncology
  • Medical Director, Brain Tumor Institute
  • Oncologist
    • Research Fellowship, Molecular Biology of Brian Tumors, Children’s National Medical Center, Washington, DC, (2001-2002)
    • Fellowship, Pediatric Hematology/Oncology, Children’s National Medical Center, Washington, DC, (1998-2001)
    • Residency, Pediatrics, University of Vermont, Burlington, VT, (1995-1998)
    • M.D., Medicine, Jefferson Medical College, Philadelphia, PA, (1991-1995)
    • B.A., English Literature, Pennsylvania State University, State College, PA, (1987-1991)
  • Brian R. Rood, M.D., is a professor of pediatrics in the Center for Cancer and Blood Disorders at Children’s National Hospital whose primary clinical focus is pediatric neuro-oncology. Dr. Rood joined the faculty of Children’s National in 2002 after completing a fellowship in pediatric hematology/oncology as well as a research fellowship in the molecular biology of brain tumors, both at Children’s National and Children’s National Research Institute.

    Dr. Rood is the medical director of the neuro-oncology program in the Brain Tumor Institute at Children’s National Hospital and a principal investigator in the Center for Cancer and Immunology Research at Children's National Research Institute. He is also professor of pediatrics at the George Washington University School of Medicine and Health Sciences and adjunct professor at the Fralin Biomedical Research Institute at Virginia Tech. He received a B.A. in English Literature from The Pennsylvania State University and an M.D. from Jefferson Medical College. He completed his pediatric residency training at the University of Vermont. He received his pediatric hematology/oncology training at Children's National Hospital and also completed a research fellowship in the molecular biology of pediatric brain tumors at the Children’s Research Institute. Currently, Dr. Rood’s research focuses on the application of proteomics in cancer biology investigation, neoantigen identification and biomarker development. He has also been studying the contribution of germline microsatellite genotypes to pediatric brain tumor predisposition. He currently serves as the executive co-chair of the Children’s Brain Tumor Network, an international consortium of 28 institutions that maintains the world’s largest pediatric brain tumor tissue and data repository which are freely provided to the research community to support the development of ground-breaking clinical trials through data-driven precision medicine. 

    Dr. Rood has two children. His favorite pastimes include designing and building furniture, sailing, reading, and playing the mandolin.